Michael Kaseta's Net Worth
$3.1 Million
Who is Michael Kaseta?
Michael Kaseta has an estimated net worth of $3.1 Million. This is based on reported shares across multiple companies, which include Liquidia Corp, Aralez Pharmaceuticals Inc., and ALIMERA SCIENCES INC.
SEC CIK
Michael Kaseta's CIK is 0001724346
Past Insider Trading and Trends
2022 was Michael Kaseta's most active year for acquiring shares with 8 total transactions. Michael Kaseta's most active month to acquire stocks was the month of December. 2024 was Michael Kaseta's most active year for disposing of shares, totalling 10 transactions. Michael Kaseta's most active month to dispose stocks was the month of February. 2022 saw Michael Kaseta paying a total of $141,758.33 for 293,054 shares, this is the most they've acquired in one year. In 2024 Michael Kaseta cashed out on 121,663 shares for a total of $313,299.06, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Liquidia Corp (LQDA) Snapshot price: $9.2988
CFO and COO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.24% | -3.89K |
$11.11 | -$43,231.17 | 311.08K |
Scheduled
|
Oct 14
| ||
Form 4
| +0.40% | 1.26K |
$9.50 | -$10,250.18 | 314.97K |
Scheduled
|
Aug 30 - Sep 3
| ||
Form 4
| -1.23% | -3.91K |
$12.53 | -$48,942.18 | 312.39K |
Scheduled
|
Jul 12
| ||
Form 4
| +0.40% | 1.25K |
$14.55 | -$15,917.70 | 316.3K |
Scheduled
|
May 31 - Jun 3
| ||
Form 4
| -0.99% | -3.14K |
$14.58 | -$45,722.88 | 315.05K |
Scheduled
|
Apr 12
| ||
Form 4
| -2.99% | -9.82K |
$15.82 | -$192,466.12 | 318.18K |
Scheduled
|
Mar 15 - Mar 18
| ||
Form 4
| +78.28% | 143.25K |
—
|
—
| 326.25K |
Jan 11 - Jan 15
| |||
Form 4
| +1.30% | 2.34K |
—
|
—
| 183K |
Nov 30
| |||
Form 4
| +1.31% | 2.34K |
—
|
—
| 180.66K |
Aug 31
| |||
Form 4
| +1.35% | 2.34K |
—
|
—
| 176.6K |
May 31
| |||
Form 4/A
| +6.89% | 1.93K |
$4.90 | $9,450.97 | 29.88K |
Aug 31
| |||
Form 4
| +5.69% | 9.38K |
—
|
—
| 174.25K |
Feb 28
| |||
Form 4
| +329.14% | 124.67K |
—
|
—
| 162.54K |
Jan 11
| |||
Form 4
| +26.78% | 8K |
$5.99 | $47,920.00 | 37.88K |
Sep 13
| |||
Form 4
| +6.89% | 1.93K |
$4.90 | $9,450.97 | 29.88K |
Aug 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 28
| |||
Form 4
| +202.16% | 18.7K |
$4.01 | $74,936.39 | 27.95K |
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
Form 4
|
∞
| 9.25K |
—
|
—
| 9.25K |
Nov 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aralez Pharmaceuticals Inc. No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +500.00% | 12.5K |
—
|
—
| 15K |
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALIMERA SCIENCES INC (ALIM) Snapshot price: $5.57
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HERON THERAPEUTICS, INC. /DE/ (HRTX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 37.88K |
—
|
—
| 37.88K |
Nov 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||